ObjectivesInfection with HIV leads to progressive CD4 T-cell loss, resulting in AIDS. Apoptosis is the main mechanism for the loss of infected and bystander cells, but the complex interacting factors inducing and inhibiting apoptosis are not fully understood. Mitochondrial dysfunction is a pivotal step of the apoptotic cascade and can result in reduced mitochondrial membrane potential. MethodsThe mitochondrial membrane potential of peripheral blood mononuclear cells (PBMC) was measured by flow cytometry using the dye JC-1 (Molecular Probes Inc). Apoptotic cells were identified using the Annexin V assay (Becton Dickinson GmbH). ResultsThe mitochondrial membrane potential of PBMC was significantly decreased and apoptotic cell rate was increased in HIV-infected therapy-naïve patients compared with HIV-negative controls. There was a highly significant correlation between the mitochondrial membrane potential and the rate of apoptosis. CD4 cell count was correlated negatively to the apoptotic rate and positively to the mitochondrial membrane potential. ConclusionsThe JC-1 assay is a sensitive tool to detect changes of mitochondrial membrane potential associated with apoptosis in HIV-infected therapy-naïve patients. We could show in vivo that a reduction of mitochondrial membrane potential is correlated to apoptosis of PBMC, CD4 cell count and HIV viral load during HIV infection. IntroductionInfection with HIV leads to progressive CD4 T-cell death, resulting in the development of AIDS. The mechanisms triggering this CD4 T-cell death are still not understood fully, but data indicate that apoptosis plays a major role [1]. There is a correlation between the extent of apoptosis and disease progression [2,3], and highly active antiretroviral therapy is associated with a lower level of CD4 T-cell apoptosis in HIV-1 infected patients [4][5][6][7].Both infected and uninfected CD4 T-cells can die during HIV-1 infection by different cell death pathways, but HIV-1 induced bystander CD4 T-cell demise is now recognized as pivotal to the development of immunodeficiency. Chronically increased activation of the immune system may contribute directly to progressive CD4 T-cell depletion, irrespective of viral load [8,9]. Upon receiving a death signal, a cascade of molecular events resulting in the activation or inactivation of numerous cellular proteins is initiated, leading to morphological and biochemical changes such as plasma membrane blebbing, DNA fragmentation and mitochondrial dysfunction. The regulators of the apoptotic pathway exert their function primarily at the mitochondrion by either preventing or inducing mitochondrial dysfunction [10,11]. Furthermore, there is evidence that resistance to apoptosis in persistently infected cells involves direct modulation of the mitochondrial pathway [1]. The measurement of the mitochondrial membrane potential of peripheral blood mononuclear cells (PBMC) might be a useful tool to [24]. In the early stages of apoptosis, there are changes at the cell surface. One of these plasma membrane al...
We report the case of a 31-year-old immunosuppressed, liver transplanted man, with acute measles infection. The vaccinated patient had been exposed to measles during a known measles epidemic in public schools in Austria between January and April 2008. Measles infection triggered an episode of acute liver transplant rejection. The diagnosis of measles infection was made clinically and by serologic tests. Transplant rejection was diagnosed by liver biopsy. The transplant rejection was treated successfully. Liver transplant patients are at an increased risk for infection during epidemic outbreaks, even after pre-transplant vaccination, as immunity may wane over time.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.